Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Acquisition

29 Jul 2025 17:10

RNS Number : 0649T
Compagnie de Saint-Gobain
29 July 2025
 

SAINT-GOBAIN reinforcES ITS construction chemicals platform WITH three bolt-on ACQUISITIONsin North america, Italy and peru

 

 

Saint-Gobain reinforces its construction chemicals platform with:

 

· Two acquisitions securing key technologies that it will scale across the Group, Interstar Materials in North America and Isoltech in Italy;

 

· A local acquisition in Peru, Soquimic, enhancing Saint-Gobain's footprint in this high-growth market.

 

Interstar Materials is a leading North American manufacturer of high-performance pigments for all segments of concrete including ready-mix and precast concrete. Established in 1987, it operates two facilities in Canada (Quebec and Alberta) and one in the United States (Illinois). Concrete coloring has become popular amongst architects and contractors, with granular pigments having many advantages over liquid or powder pigments: they yield more vibrant colors, are simple to transport and store, easy to handle without temperature constraints and more environmentally friendly. Interstar will enrich Saint-Gobain's range of solutions for the growing demand in decorative concrete solutions for façade, flooring and architectural elements and benefit from the Group's strong presence in construction chemicals in North America.

 

Isoltech is an Italian manufacturer of additives specialized in cellular concrete technology used in the production of lightweight concrete. Established in 1987, it operates a production facility in Verdellino, northern Italy. Its solutions are widely recognized for their excellent thermal and acoustic insulation, as well as their fire resistance, recyclability, vapor and water permeability. Isoltech serves the ready-mix concrete, precast and screed markets.

 

Soquimic is a leading manufacturer of concrete admixtures in Peru. Established in 2013, the company has two plants located in Lurin, near Lima, and in Arequipa, in southern Peru. This transaction will enrich Saint-Gobain's range of solutions and accelerate its growth in Peru, following the acquisition of Z Aditivos in 2021, offering cement additives, and will complement the offering of Weber tile adhesives and facade renders.

 

Interstar, Isoltech and Soquimic generate revenues of around €25 million. They will benefit from Chryso's expertise, innovation and R&D capabilities to support customers in the development of low-carbon materials and from Saint-Gobain's global geographical footprint to expand their portfolio and value proposition in the market.

 

These acquisitions are in line with Saint-Gobain's strategic plan, "Grow & Impact" which aims to both strengthen the Group's worldwide leadership and accelerate its growth by enriching its range of solutions for light and sustainable construction.

 

About Saint-Gobain

Worldwide leader in light and sustainable construction, Saint-Gobain designs, manufactures and distributes materials and services for the construction and industrial markets. Its integrated solutions for the renovation of public and private buildings, light construction and the decarbonization of construction and industry are developed through a continuous innovation process and provide sustainability and performance. The Group, celebrating its 360th anniversary in 2025, remains more committed than ever to its purpose "MAKING THE WORLD A BETTER HOME".

 

€46.6 billion in sales in 2024

More than 161,000 employees, locations in 80 countries

Committed to achieving net zero carbon emissions by 2050

 

For more information about Saint-Gobain, visit www.saint-gobain.com and follow us on X @saintgobain

Analyst/investor relations

Press relations

Vivien Dardel:

+33 1 88 54 29 77

Patricia Marie:

+33 1 88 54 26 83

Floriana Michalowska:

+33 1 88 54 19 09

Laure Bencheikh:

+33 1 88 54 26 38

Alix Sicaud:

+33 1 88 54 38 70

Yanice Biyogo: 

 +33 1 88 54 27 96

James Weston: 

+33 1 88 54 01 24

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQRLMFTMTMTBAA
Date   Source Headline
14th Apr 20207:12 amRNSCo-optation of a director
30th Mar 20207:07 amRNSIssue of Debt
23rd Mar 20207:34 amRNSCoronavirus pandemic update
10th Mar 20207:06 amRNSDisposal
28th Feb 20204:35 pmRNSPrice Monitoring Extension
27th Feb 20204:59 pmRNSFull-Year Results 2019
30th Jan 20207:02 amRNSAcquisition
24th Jan 20207:00 amRNSResolution of asbestos liabilities
21st Jan 20207:06 amRNSCDP Climate change A List
7th Jan 20205:07 pmRNSAcquisition
7th Jan 20207:07 amRNSAcquisition
6th Jan 20205:05 pmRNSDisposal
20th Dec 20197:08 amRNSDisposal
2nd Dec 20197:35 amRNSSaint-Gobain completes the divestment of DMTP
29th Nov 20195:15 pmRNSNew production line
29th Nov 20197:07 amRNSCancelation of shares
13th Nov 20197:00 amRNSAcquisition
4th Nov 20195:08 pmRNSDisposal
4th Nov 20197:04 amRNSDisposal
25th Oct 201912:18 pmRNS3rd Quarter Results
16th Oct 20197:07 amRNSAcquisition
7th Oct 20195:16 pmRNSDisposal
1st Oct 20195:07 pmRNSDisposal
30th Sep 20195:39 pmRNSDisposal
30th Sep 20197:21 amRNSDisposal
23rd Sep 20195:08 pmRNSCommitment
12th Sep 20196:15 pmRNSAmended Final Terms
26th Jul 20197:00 amRNSHalf-year Report
18th Jul 20195:16 pmRNSDisposal
1st Jul 20197:07 amRNSAccounting standards
19th Jun 20197:54 amRNSDisposal
14th Jun 20195:02 pmRNSCancellation of shares
7th Jun 20197:00 amRNSAGM Statement
28th May 20196:11 pmRNSAcquisition
20th May 20197:48 amRNSDisposal
14th May 20195:44 pmRNSFinal Terms
14th May 20195:16 pmRNSDisposal
2nd May 20195:32 pmRNSFinal Terms
25th Apr 20194:59 pmRNS1st Quarter Results
24th Apr 20197:08 amRNSAcquisition
8th Apr 20199:29 amRNSFinal Terms
25th Mar 20195:38 pmRNSFinal Terms
22nd Mar 20193:50 pmRNSFinal Terms
15th Mar 20197:00 amRNSFinal Terms
15th Mar 20197:00 amRNSFinal Terms
7th Mar 201910:24 amRNSStabilisation Notice
6th Mar 20195:34 pmRNSIssue of Debt
6th Mar 20199:01 amRNSStabilisation Notice
5th Mar 20195:42 pmRNSProspectus Supplement
21st Feb 20195:13 pmRNSAnnual Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.